STOCK TITAN

Alnylam Pharmaceuticals, Inc. (ALNY) Revenue by Year

ALNY

Alnylam Pharmaceuticals, Inc. generated $3.7B in revenue in fiscal year 2025. This represents an increase of 65.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Alnylam Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $3.7B
YoY +65.2%
5Y CAGR +49.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ALNY Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$3.7B+65.2%$2.2B+23.0%$1.8B+76.2%$1.0B+22.9%$844.3M+71.3%$492.9M+124.3%$219.8M+193.4%$74.9M-16.7%$89.9M+90.7%$47.2MN/AN/AN/AN/AN/A

ALNY Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$1.3B+66.9%N/AN/A$1.2B+149.3%$773.7M+17.3%N/A$593.2M+34.9%$500.9M-33.3%$659.8M+107.0%$494.3M+54.8%$439.7M+31.2%$750.5M+184.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Alnylam Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Alnylam Pharmaceuticals, Inc.'s revenue in fiscal year 2025?

Alnylam Pharmaceuticals, Inc. generated $3.7B in revenue in fiscal year 2025.

How fast is Alnylam Pharmaceuticals, Inc.'s revenue growing?

Alnylam Pharmaceuticals, Inc. (ALNY) revenue rose by 65.2% year over year, from $2.2B to $3.7B in fiscal year 2025.

What was Alnylam Pharmaceuticals, Inc.'s revenue in the most recent quarter?

Alnylam Pharmaceuticals, Inc. (ALNY) reported $1.3B in revenue in Q2 2026. This represents an increase of 66.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Alnylam Pharmaceuticals, Inc. (ALNY) reported on that line in every period on record.